Sharemaestro Newsreel

Signaturefd LLC Buys 22,148 Shares of Novo Nordisk A/S $NVO

Saratoga Research & Investment Management Sells 200,320 Shares of Novo Nordisk A/S $NVO

Merit Financial Group LLC Has $53.25 Million Stock Position in Johnson & Johnson $JNJ

Johnson & Johnson $JNJ Stock Holdings Decreased by Gateway Investment Advisers LLC

Monument Capital Management Decreases Stake in Gilead Sciences, Inc. $GILD

Monument Capital Management significantly reduced its stake in Gilead Sciences by 56.1% in the second quarter, selling over 15,000 shares. Despite this, institutional investors collectively own 83.67% of the company, and analysts maintain a "Moderate Buy" consensus with an average price target of $158.04. …

Mirae Asset Global Investments Co. Ltd. Increases Stake in Novo Nordisk A/S $NVO

Bernstein Adjusts PT on Regeneron Pharmaceuticals to $756 From $753, Maintains Market Perform Rating

Bernstein has increased its price target for Regeneron Pharmaceuticals (REGN) to $756 from $753, while maintaining a "Market Perform" rating on the stock. This adjustment reflects a modest change in the analyst's valuation, indicating a continued neutral stance on the company's stock performance. The …

17,243 Shares in Johnson & Johnson $JNJ Bought by Thomasville National Bank

Contineum Therapeutics (CTNM): Balyasny group reports 7.14% stake in 13G/A filing

Balyasny Asset Management and its affiliated entities have reported a 7.14% beneficial ownership stake in Contineum Therapeutics (CTNM) Class A common stock through a Schedule 13G/A filing. This equates to 2,335,550 shares, with sole voting and dispositive power, based on 32,723,877 shares outstanding as …

Arcutis Biotherapeutics (NASDAQ:ARQT) Matches Navellier's Growth Playbook With Accelerating Fundamentals

Rallybio Corp (RLYB) sees Balyasny group report 0% ownership in 13G/A

Nektar Therapeutics (NKTR) adds $1.02B cash while posting $85.5M loss

MiNK Therapeutics (NASDAQ:INKT) Stock Rating Lowered by Zacks Research

QV Investors Inc. Acquires 81,870 Shares of Novo Nordisk A/S $NVO

Johnson & Johnson $JNJ Shares Bought by Interchange Capital Partners LLC

Bristol Myers Squibb announces new $2.3bn campus in the US

Bristol Myers Squibb has announced a new $2.3 billion multi-modal manufacturing campus in Houston, Texas, creating nearly 500 skilled jobs. This investment is part of BMS's $40 billion commitment to the US, aiming to accelerate the delivery of next-generation medicines. The campus's modular design …

Balyasny Asset Management (CBIO) discloses 6.03% Crescent Biopharma ownership

Balyasny Asset Management L.P. and its affiliated entities have reported a 6.03% beneficial ownership stake in Crescent Biopharma, Inc., totaling 1,662,917 shares of Class A common stock. This ownership is primarily held through Atlas Private Holdings (Cayman) Ltd. and Atlas Diversified Master Fund, Ltd. …

Zacks.com featured highlights include BioMarin Pharmaceutical, Invesco, Centene Corporation, Hewlett Packard Enterprise and Gibraltar Industries

For Immediate Release Chicago, IL – August 14, 2026 – Stocks in this week's article are BioMarin Pharmaceutical BMRN, Invesco IVZ, Centene Corporation CNC, Hewlett Packard Enterprise HPE and Gibraltar Industries ROCK. 5 Undervalued Price-to-Book Stocks Worth Buying in August There are several different …

Centene (CNC) Stock Still Looks Like A Bargain As Shares Jumped 145%

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Centene stock has surged over the past year, yet the current checks still suggest it leans on the cheap side, so investors are weighing how …

Eton Pharmaceuticals jumps on strong Q2 print, 2026 guidance

Shares in Eton Pharmaceuticals (ETON [https://seekingalpha.com/symbol/ETON]) rallied 25% in premarket trading on Friday, driven by a solid quarterly print and 2026 revenue forecast, which the company said would exceed $145M while targeting adjusted EBITDA margin above 35%. Chief executive officer Sean Brynjelsen said the …

Handelsbanken Fonder AB Buys 28,130 Shares of Zimmer Biomet Holdings, Inc. $ZBH

Handelsbanken Fonder AB increased its stake in Zimmer Biomet Holdings, Inc. by 22.7% in the second quarter, purchasing an additional 28,130 shares to bring its total to 152,064 shares valued at approximately $13.1 million. Zimmer Biomet exceeded Q2 earnings expectations with $2.07 EPS and …

ANI Pharmaceuticals (ANIP) Could Be 34% Undervalued As Earnings And Guidance Hold

Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Receives Average Recommendation of "Moderate Buy" from Brokerages

Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) has received an average "Moderate Buy" recommendation from analysts, with an average 12-month price target of $35.57. The company recently exceeded quarterly earnings and revenue expectations, reporting $0.11 EPS against an anticipated $0.06 and $129.86 million in revenue versus $118.85 …

Sei Investments Co. Makes New Investment in Aclaris Therapeutics, Inc. $ACRS

Sei Investments Co. Buys Shares of 99,627 MeiraGTx Holdings PLC $MGTX

Nektar: Q2 Earnings Snapshot

The article provides a snapshot of Nektar's Q2 earnings. No specific financial details are available in the provided content, as the main article text was not included.

Palisade Bio, Inc. (NASDAQ:PALI) Given Consensus Recommendation of "Buy" by Brokerages

Palisade Bio, Inc. (NASDAQ:PALI) has received a consensus "Buy" recommendation from brokerages, with an average one-year target price of $9.00. The article details recent analyst ratings, including several "buy" and "strong-buy" recommendations, alongside some changes to "hold" and "sell" ratings. It also highlights recent …

Confluence Wealth Services Inc. Acquires 7,986 Shares of Gilead Sciences, Inc. $GILD

Confluence Wealth Services Inc. significantly increased its stake in Gilead Sciences, Inc. (NASDAQ:GILD) by 251.4% during the second quarter, acquiring an additional 7,986 shares, bringing its total holdings to 11,162 shares valued at $1.41 million. Gilead reported strong Q2 revenue of $7.80 billion, exceeding …

Brown Shipley& Co Ltd Acquires New Shares in Thermo Fisher Scientific Inc. $TMO

Brown Shipley & Co Ltd has acquired 10,509 shares of Thermo Fisher Scientific Inc. (NYSE:TMO) valued at approximately $5.27 million, making it their 11th largest holding. Thermo Fisher Scientific recently reported strong quarterly earnings, exceeding analyst estimates with an EPS of $6.03 and revenue …

Exchange Traded Concepts LLC Cuts Stock Holdings in Novo Nordisk A/S $NVO

Stock index futures largely flat after S&P 500 closes at record high

[Wall Street New York stock exchange stock market] alexsl Stock index futures were muted on Friday after the S&P 500 closed at a record high in the previous session. Dow futures (INDU [https://seekingalpha.com/symbol/INDU]) -0.12%, S&P 500 futures (SPX [https://seekingalpha.com/symbol/SPX]) +0.02%, and Nasdaq futures (US100:IND) …

Assenagon Asset Management S.A. Has $2.03 Million Position in REGENXBIO Inc. $RGNX

Assenagon Asset Management S.A. significantly reduced its stake in REGENXBIO Inc. by 82.7% in the second quarter, now holding 169,279 shares valued at $2.03 million. Despite this, institutional investors still own a substantial 88.08% of the company. REGENXBIO recently surpassed analyst estimates for quarterly …

Gilead Sciences, Inc. $GILD Stock Position Lifted by Exchange Traded Concepts LLC

Dimensional Fund Advisors LP Has $1.85 Million Stock Holdings in Tempus AI, Inc. $TEM

New Strong Sell Stocks for August 14th

Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today: Amphastar Pharmaceuticals, Inc. AMPH is a bio-pharmaceutical company. The Zacks Consensus Estimate for its current year earnings has been revised 8% downward over the last 60 days. Chunghwa Telecom Co., …

California State Teachers Retirement System Raises Position in NeoGenomics, Inc. $NEO

The California State Teachers Retirement System significantly increased its stake in NeoGenomics, Inc. (NASDAQ:NEO) by 56.8% in the first quarter, now owning 194,103 shares valued at $1.44 million. This move is reflective of a broader positive sentiment from institutional investors, who collectively own 98.5% …